Usefulness of brain natriuretic peptide to evaluate patients with heart failure treated with cardiac resynchronization;Utilidad del péptido natriurético BNP en la evaluación de pacientes con insuficiencia cardíaca tratados con resincronización cardíaca

Revista Espanola de Cardiologia

Volumn 57, Issue 4, 2004, Pages 299-305

  Hernández, Antonio ^a   Miguelañez Díaz, Mercedes ^a   Escobar Cervantes, Carlo ^a   Blanco Tirados, Blanca ^a   Marín, Irene ^a   Bernal, Enrique ^a   Zamora, Javier ^a   Cordova González, Fernando J ^a   Alfonso Pérez, Manuel ^a   Limón, Lilianna ^a   González Rebollo, José M ^a   Moya Mur, José L ^a   Moro, Concepción ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Diagnosis; Heart failure; Pacemaker

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; LABORATORY TEST; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROTEIN BLOOD LEVEL; QRS COMPLEX; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY;

EID: 18344397600     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13059721     Document Type: Article

References (18)

1. Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction. J Am Coll Cardiol 1998;32:476-82.
2. Cazeau S, Leclerq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects on multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;12:873-80.
3. Leclerq Ch, Kass D. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39:194-201.
4. Osca J, Quesada A, Arnau M, Osa A, Hervas I, Almenar L, et al. Péptido cerebral natriurético. Valor diagnó stico en la insuficiencia cardíaca. Rev Esp Cardiol 2002;55:7-15.
5. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Circulation 1997;96: 509-16.
6. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent car setting. J Am Coll Cardiol 2001;37:379-85.
7. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;3:161-7.
8. McCullough P, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-22.
9. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, VonScheidt W, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934-41.
10. Maisel A. B-Type natriuretic peptide levels: diagnostic an prognostic in congestive heart failure. What's next? Circulation 2002; 105:2328-31.
11. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Chronic benefit as a result of pacing in congestive heart failure: results of the Path CHF trial. J Cardiac Fail 1999;5:1-78.
12. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation 2002;106:2145-61.
13. Abraham W, Fisher W, Smith A, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
14. Clerico A, Del Ry S, Maffei S, Prositera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med 2002; 40:371-7.
15. Cosin J, Hernándiz A, Díez J, Capdevila C, Salvador A, Diago J. Valor del nivel de NT pro BNP en población adulta extrahospitalaria. Rev Esp Cardiol 2003;56:236-44.
16. Sinha A, Filzmaier K, Breithardt O, Kunz D, Graf J, Markus K, et al. Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. Am J Cardiol 2003; 91:755-7.
17. García Bolao I, Macías A, Alegría E, Berenguell A, Gavira J, Azcárate P. Tratamiento de la insuficiencia cardí aca avanzada mediante estimulación biventricular. Experiencia inicial en una serie de 22 casos consecutivos. Rev Esp Cardiol 2003; 56:245-52.
18. Leon A, Greenberg J, Kanuru N, Baker CM, Mera FV, Smith AL, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation. J Am Coll Cardiol 2002;39: 1258-63.